Sonnet Biotherapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,000 | $104 |
Gross Profit | -22 | -22 | -886 | -21 |
EBITDA | -3,806 | -4,207 | -2,827 | -3,152 |
EBIT | -3,828 | -4,229 | -2,849 | -3,173 |
Net Income | -3,775 | -3,491 | -3,160 | -3,128 |
Net Change In Cash | 0 | 0 | 1,000 | 104 |
Free Cash Flow | -1,759 | -2,471 | -2,910 | -3,170 |
Cash | 321 | 2,059 | 4,861 | 149 |
Basic Shares | 3,965 | 3,921 | 2,022 | 650 |
Annual Financials
| Values in thousands | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|
Revenue | $18 | $147 | $349 | $483 |
Gross Profit | 18 | 147 | -21,094 | 483 |
EBITDA | -11,766 | -18,716 | -29,576 | -24,992 |
EBIT | -11,849 | -18,792 | -29,669 | -25,087 |
Net Income | -7,437 | -18,832 | -29,774 | -25,005 |
Net Change In Cash | 18 | 147 | 349 | 483 |
Free Cash Flow | -8,607 | -21,785 | -28,583 | -22,555 |
Cash | 149 | 2,274 | 3,052 | 27,622 |
Basic Shares | 655 | 129 | 24 | 9 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.95 |
2025-03-31 | -$0.89 |
2024-12-31 | -$1.56 |
2024-09-30 | -$10.39 |
